Current problems of amebiasis in Japan and recent advances in amebiasis research

T Nozaki1

  • 1Department of Parasitology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan. nozaki@nih.go.jp

Insights

Amebiasis, a parasitic infection, is prevalent in specific groups in Japan. Understanding its unique biology may lead to new treatments and preventative strategies for amebiasis.

Area of Science:

  • Medical Parasitology
  • Infectious Diseases
  • Tropical Medicine

Background:

  • Amebiasis presents a significant health challenge in Japan, particularly affecting male homosexuals and institutionalized populations.
  • Current diagnostic, treatment, and prevention methods for amebiasis have limitations that require addressing.

Purpose of the Study:

  • To review current approaches to amebiasis diagnosis, chemotherapy, and prophylaxis.
  • To highlight recent advancements in basic amebiasis research, focusing on unique parasite biology.
  • To explore how understanding parasite mechanisms can inform the development of novel anti-amebiasis therapies and vaccines.

Main Methods:

  • Literature review of diagnostic, chemotherapeutic, and prophylactic measures for amebiasis.
  • Analysis of recent findings in basic research on the unique metabolism and cellular organization of the *Entamoeba histolytica* parasite.
  • Elucidation of pathogenic mechanisms through the study of parasite-specific features.

Main Results:

  • Discussion of the challenges and limitations associated with existing amebiasis management strategies.
  • Presentation of novel findings regarding the unique metabolic pathways and intracellular structures of the amebiasis-causing protist.
  • Identification of key parasite features relevant to pathogenicity.

Conclusions:

  • Further research into the unique biological characteristics of the *Entamoeba histolytica* parasite is crucial.
  • Understanding these unique features can enhance our knowledge of amebiasis pathogenesis.
  • This knowledge holds potential for developing effective new drugs and vaccines against amebiasis.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...